Short Interest in Psykey, Inc. (OTCMKTS:CEOS) Drops By 96.2%

Psykey, Inc. (OTCMKTS:CEOSGet Rating) was the recipient of a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 2,400 shares, a decline of 96.2% from the April 15th total of 63,000 shares. Based on an average daily trading volume, of 160,300 shares, the short-interest ratio is currently 0.0 days.

Shares of Psykey stock traded down $0.00 on Thursday, hitting $0.06. 48,725 shares of the company’s stock traded hands, compared to its average volume of 297,524. Psykey has a one year low of $0.03 and a one year high of $0.17. The company has a fifty day moving average of $0.07 and a two-hundred day moving average of $0.07.

Psykey Company Profile (Get Rating)

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.

Featured Articles

Receive News & Ratings for Psykey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psykey and related companies with MarketBeat.com's FREE daily email newsletter.